AKT1 and cardiac hypertrophy: Some cellular/molecular pathways, including the mitochondrial pathway, phosphoinositide 3-kinase (PI3K), AKT, and mammalian target of rapamycin (mTOR), are involved in the progression of cardiac hypertrophy [1, 4, 16].